<DOC>
	<DOCNO>NCT00532259</DOCNO>
	<brief_summary>Autologous peripheral blood stem cell transplantation combine high dose chemotherapy treatment choice give patient diffuse large-B cell lymphoma ( DLBCL ) follow relapse disease . Although many people cure lymphoma therapy , disease come back certain proportion patient . The purpose study test safety effectiveness monoclonal antibody , CT-011 , patient DLBCL receive autologous peripheral blood stem cell transplantation . All final eligible patient receive IV infusion CT-011 Day 1 ( 30 90 day post autologous PBSCT ) . Treatment repeat every 42 day total three course treatment visit Days 1 , 43 , 85 . Follow-up safety clinical outcome conduct throughout study till 18 month post autologous PBSCT . Approximately 70 patient participate study .</brief_summary>
	<brief_title>CT-011 MAb DLBCL Patients Following ASCT</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>1 . Patient 's age 18 year old , gender . 2 . Confirmed Diffuse Large Bcell Lymphoma , transform follicular lymphoma , diffuse mixed cell lymphoma primary mediastinal large cell lymphoma Bcell lineage . 3 . The lymphoma chemosensitive . 4 . The lymphoma progress since pretransplant chemotherapy . 5 . ECOG performance status 01 . 1 . Serious illness . 2 . Active autoimmune disease . 3 . Type 1 diabetes . 4 . Known immune deficiency . 5 . Clinical evidence primary secondary brain spinal cord involvement lymphoma . 6 . Active bacterial , fungal , viral infection . 7 . Positive HIV , Hepatitis B surface antigen plus viremia , Hepatitis C antibody plus viremia . 8 . Pregnant nursing ( positive pregnancy test ) . 9 . Other concurrent clinical study investigational therapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Lymphoma , Large B-Cell , Diffuse</keyword>
	<keyword>Transformed Follicular Lymphoma</keyword>
	<keyword>Stem cell transplantation</keyword>
	<keyword>Relapsed</keyword>
	<keyword>Refractory</keyword>
</DOC>